These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32799713)

  • 1. Onychomycosis in children - review on treatment and management strategies.
    Gupta AK; Venkataraman M; Shear NH; Piguet V
    J Dermatolog Treat; 2022 May; 33(3):1213-1224. PubMed ID: 32799713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.
    Gupta AK; Venkataraman M; Abramovits W; Guenin EP
    Skinmed; 2021; 19(3):206-210. PubMed ID: 34303391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis.
    Gupta AK; Venkataraman M; Shear NH; Piguet V
    Dermatol Ther; 2020 Jul; 33(4):e13613. PubMed ID: 32418289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Timeline of Onychomycosis Therapy and Future Directions.
    Geizhals S; Lipner SR
    Skinmed; 2020; 18(6):367-371. PubMed ID: 33397567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents.
    Del Rosso JQ
    J Clin Aesthet Dermatol; 2014 Jul; 7(7):10-8. PubMed ID: 25053979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of adverse events with topical onychomycosis medications reported to the United States Food and Drug Administration.
    Wang Y; Lipner SR
    Arch Dermatol Res; 2020 Oct; 312(8):581-586. PubMed ID: 32076805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efinaconazole 10% and Tavaborole 5% Penetrate Across Poly-ureaurethane 16%: Results of In Vitro Release Testing and Clinical Implications of Onychodystrophy in Onychomycosis.
    Adigun CG; Vlahovic TC; McClellan MB; Thakker KD; Klein RR; Elstrom TA; Ward DB
    J Drugs Dermatol; 2016 Sep; 15(9):1116-20. PubMed ID: 27602975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efinaconazole and Tavaborole.
    Poulakos M; Grace Y; Machin JD; Dorval E
    J Pharm Pract; 2017 Apr; 30(2):245-255. PubMed ID: 26873506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients.
    Vlahovic TC; Gupta AK
    Expert Rev Anti Infect Ther; 2022 Jan; 20(1):3-15. PubMed ID: 34106031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management.
    Gupta AK; Venkataraman M; Talukder M
    Drugs Aging; 2022 Mar; 39(3):191-198. PubMed ID: 35102533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onychomycosis: Treatment and prevention of recurrence.
    Lipner SR; Scher RK
    J Am Acad Dermatol; 2019 Apr; 80(4):853-867. PubMed ID: 29959962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor Antifungal Coverage for Onychomycosis in a Cross-Sectional Analysis of Medicaid Formularies.
    Falotico JM; Lipner SR
    J Am Podiatr Med Assoc; 2022; 112(5):. PubMed ID: 36251605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal therapy for onychomycosis in children.
    Feldstein S; Totri C; Friedlander SF
    Clin Dermatol; 2015; 33(3):333-9. PubMed ID: 25889135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efinaconazole in Onychomycosis.
    Gupta AK; Talukder M
    Am J Clin Dermatol; 2022 Mar; 23(2):207-218. PubMed ID: 34902110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
    Eichenfield LF; Friedlander SF
    J Drugs Dermatol; 2017 Feb; 16(2):105-109. PubMed ID: 28300851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efinaconazole: a new topical treatment for onychomycosis.
    Gupta AK; Simpson FC
    Skin Therapy Lett; 2014; 19(1):1-4. PubMed ID: 24570290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis: a review.
    Gupta AK; Stec N; Summerbell RC; Shear NH; Piguet V; Tosti A; Piraccini BM
    J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):1972-1990. PubMed ID: 32239567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
    Rosen T; Stein Gold LF
    Semin Cutan Med Surg; 2016 Mar; 35(3 Suppl 3):S51-5. PubMed ID: 27074700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.